Table 5.

Frequency of best-corrected visual acuity change between at the point of choroidal neovascularization detection and 1-, 3-year thereafter.

	BCVA at 1-year follow up (n = 28)
	logMAR ≤ 0.3	0.3<logMAR < 1	logMAR ≥ 1	Total
BCVA at CNV detection
logMAR ≤ 0.3	21 (75.0)	1 (3.6)	0	22 (78.6)
0.3 < logMAR < 1	3 (10.7)	3 (10.7)	0	6 (21.4)
logMAR ≥ 1	0	0	0	0
Total	24 (85.7)	4 (14.3)	0	28 (100)

	BCVA at 3-year follow up (n = 17)
	logMAR ≤0.3	0.3 < logMAR < 1	logMAR ≥1	Total
BCVA at CNV detection
logMAR ≤0.3	14 (82.4)	1 (5.9)	0	15 (88.2)
0.3 < logMAR < 1	0	2 (11.8)	0	2 (11.8)
logMAR ≥1	0	0	0	0
Total	14 (82.4)	3 (17.6)	0	17 (100)

BCVA = best-corrected visual acuity, CNV = choroidal neovascularization, logMAR = the logarithm of the minimum angle of resolution, logMAR 0.3, 20/40 in Snellen equivalent; logMAR 1, 20/200 Snellen equivalent.

Data are presented as counts, with the corresponding percentages in parenthesis.